Five Billion Mectizan Treatments Donated…and Counting: Merck & Co., Inc.’s* Dr. Allison Goldberg Interviews with Devex and the END Fund Devex In her interview with
Report from the InterAmerican Conference on Onchocerciasis XXXV In November, MDP participated in the Onchocerciasis Elimination Program for the Americas (OEPA) 35th InterAmerican Conference
Timor-Leste Eliminates LF Using Triple Therapy Congratulations to the people of Timor-Leste, the first country to achieve elimination of lymphatic filariasis (LF) using the
Welcome to Dr. Armel Evouna Mbarga The Mectizan Donation Program welcomes Dr. Armel Evouna to the role of Senior Program Officer, consultant. Dr. Evouna will
MDP remembers Rosalynn Carter: humanitarian and supporter of the fight against NTDs In 1994 President and Mrs. Carter traveled to Chad with former Merck
This year on World Neglected Tropical Diseases Day, we celebrated the progress made thanks to Merck’s* decades-long investment through the donation of Mectizan. In
Summer and autumn have seen the careful resumption of Mectizan® mass drug administration (MDA) campaigns around the world with COVID-19 safety measures in place.
A Message To Our Partners During COVID-19 Pandemic Dear Partners, To comply with recommendations issued by the WHO, CDC, and Emory University regarding the
Celebrating the Elimination of Lymphatic Filariasis in Togo The Mectizan Donation Program (MDP) held the 62nd Mectizan Expert Committee meeting in Lomé, Togo in
Congratulations to Yemen for Eliminating Lymphatic Filariasis! Click here to read the full joint MDP, MSD*, and GSK press release on Yemen’s victory. The